Innate immune recognition against SARS-CoV-2.

Area of Science:

• Immunology
• Virology
• Pathology

Background:

• Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) causes COVID-19, a disease with variable severity.
• Innate immune responses, involving pattern-recognition receptors (PRRs), pathogen-associated molecular patterns (PAMPs), and damage-associated molecular patterns (DAMPs), are crucial for controlling viral infections.
• Dysregulated innate immunity and excessive inflammation contribute to severe COVID-19 outcomes, including multi-organ failure.

Purpose of the Study:

• To review recent advancements in understanding innate immune responses to SARS-CoV-2.
• To elucidate the mechanisms of innate recognition of SARS-CoV-2.
• To explore the role of innate immunity in COVID-19 immunopathology and severe disease.

Main Methods:

• Literature review of recent research on SARS-CoV-2 and innate immunity.
• Analysis of molecular mechanisms of host pattern-recognition receptor (PRR) activation.
• Examination of downstream gene induction programs, including type I and III interferons (IFNs) and proinflammatory cytokines.

Main Results:

• Innate immune cells recognize SARS-CoV-2 via PRRs sensing PAMPs and DAMPs.
• Recognition triggers the induction of IFNs and proinflammatory cytokines, aiming to control viral replication.
• Excessive or aberrant activation of these responses can lead to detrimental systemic inflammation and tissue damage.

Conclusions:

• Innate immune responses play a dual role in COVID-19, mediating initial defense but also potentially causing immunopathology.
• Understanding SARS-CoV-2 innate recognition and inflammatory pathways is critical for developing therapeutic strategies.
• Further research is needed to precisely define the balance between protective and detrimental innate immune responses in COVID-19.